Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pathwork picks up $20m for cancer test

This article was originally published in Clinica

Executive Summary

Sunnyvale, California-based Pathwork Diagnostics has raised $20m in its second round of financing led by Abingworth. The new capital will be used to support commercialisation of Pathwork's Tissue of Origin test for determining the origin of uncertain tumours. The product was cleared by the FDA in August. The company added that some of the new capital will also go towards new product development.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043023

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel